Cadexomer Iodine Should Not Be Used for Diabetic Foot Ulcers
The most recent and authoritative guideline from the International Working Group on the Diabetic Foot (IWGDF) 2024 explicitly recommends against using topical antiseptic or antimicrobial dressings, including cadexomer iodine, for wound healing in diabetic foot ulcers. 1
Primary Recommendation
The IWGDF 2024 guidelines provide a Strong recommendation with Moderate certainty of evidence stating: "Do not use topical antiseptic or antimicrobial dressings for wound healing of diabetes-related foot ulcers." 1 This represents the highest strength of recommendation in the GRADE system and supersedes older practices.
Why This Matters for Clinical Practice
Cadexomer iodine falls under the category of topical antimicrobial dressings that are explicitly not recommended for promoting wound healing in diabetic foot ulcers 1
The guideline emphasizes that standard of care should consist of sharp debridement and basic wound dressings that absorb exudate and maintain a moist wound healing environment 1
While older research studies from 2017-2019 showed some positive effects of cadexomer iodine on wound healing 2, 3, 4, the 2024 IWGDF guidelines reviewed all available evidence and concluded the overall body of evidence does not support its use for wound healing purposes 1
Critical Distinction: Infection vs. Healing
Important caveat: The guideline specifically addresses wound healing as the outcome. If a diabetic foot ulcer is clinically infected and requires antimicrobial treatment, the management approach differs and should follow infection-specific protocols rather than wound healing protocols 1
What to Use Instead
The IWGDF 2024 guidelines recommend:
- Sharp debridement as the primary intervention, with frequency determined by clinical need 1
- Basic wound dressings that absorb exudate and maintain moist wound environment 1
- Sucrose-octasulfate impregnated dressing may be considered for non-infected neuro-ischemic ulcers that fail standard care after 2 weeks 1
FDA Labeling Context
While FDA labeling for cadexomer iodine indicates application 1-3 times daily for up to 1 week 5, this general guidance does not override disease-specific guidelines that recommend against its use in diabetic foot ulcers for wound healing 1
Bottom Line
Zero applications of cadexomer iodine should be used for the purpose of promoting wound healing in diabetic foot ulcers, based on the most current 2024 expert consensus guidelines. 1 Focus instead on sharp debridement and appropriate basic wound dressings as the foundation of care 1